237 related articles for article (PubMed ID: 25504437)
1. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.
Hsieh TH; Hsu CY; Tsai CF; Long CY; Chai CY; Hou MF; Lee JN; Wu DC; Wang SC; Tsai EM
Oncotarget; 2015 Jan; 6(1):494-509. PubMed ID: 25504437
[TBL] [Abstract][Full Text] [Related]
2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.
Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F
Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722
[TBL] [Abstract][Full Text] [Related]
4. miR-125a-5p expression is associated with the age of breast cancer patients.
He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
[TBL] [Abstract][Full Text] [Related]
5. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
Cheng DD; Yu T; Hu T; Yao M; Fan CY; Yang QC
Oncotarget; 2015 Dec; 6(40):42761-72. PubMed ID: 26498360
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
9. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibitors target HDAC5, upregulate microRNA-125a-5p, and induce apoptosis in breast cancer cells.
Hsieh TH; Hsu CY; Tsai CF; Long CY; Wu CH; Wu DC; Lee JN; Chang WC; Tsai EM
Mol Ther; 2015 Apr; 23(4):656-66. PubMed ID: 25531695
[TBL] [Abstract][Full Text] [Related]
12. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
Gao W; Chan JY; Wong TS
Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNA-125a-5p, a useful biomarker in liver diseases, correlates with disease progression.
Zheng J; Zhou Z; Xu Z; Li G; Dong P; Chen Z; Lin D; Chen B; Yu F
Mol Med Rep; 2015 Jul; 12(1):1584-90. PubMed ID: 25815788
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.
Minemura H; Takagi K; Miki Y; Shibahara Y; Nakagawa S; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2015 Nov; 106(11):1642-50. PubMed ID: 26331797
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.
Cai M; Chen Q; Shen J; Lv C; Cai L
J Cell Mol Med; 2018 Oct; 22(10):4721-4731. PubMed ID: 30117667
[TBL] [Abstract][Full Text] [Related]
17. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
19. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
20. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1.
Yan L; Yu MC; Gao GL; Liang HW; Zhou XY; Zhu ZT; Zhang CY; Wang YB; Chen X
J Cell Biochem; 2018 Nov; 119(11):8773-8783. PubMed ID: 30076753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
